SCHEMBL16229784

SCHEMBL16229784

CN1C2C1C21Cc2cc(F)c(CNS(=O)(=O)C3CCC3)cc2C1Cc1cccc(Cl)c1

nearest known ligand 0.34

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.34
DPP8 Q6V1X1 1/20 0.34
DPP9 Q86TI2 1/20 0.34
DPP7 Q9UHL4 1/20 0.34
RORC P51449 1/20 0.34
SCN9A Q15858 1/20 0.33
MDM2 Q00987 5/20 0.33
TP53 P04637 4/20 0.33
PKM P14618 2/20 0.33
MAPK1 P28482 1/20 0.31
HSD17B2 P37059 1/20 0.31
KMT2A Q03164 2/20 0.31
NPC1 O15118 1/20 0.30
SLC6A9 P48067 1/20 0.30
MEN1 O00255 1/20 0.30
GAA P10253 1/20 0.30
RECQL P46063 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16229769 0.92 DPP4 (0.34) DPP4DPP8DPP9DPP7RORC
SCHEMBL16229759 0.92 RORC (0.33) RORCKMT2A
SCHEMBL16784638 0.91 LMNA (0.34) KMT2ASLC6A9
SCHEMBL16784647 0.89 GALR3 (0.38) PKMSLC6A9
SCHEMBL16229764 0.87 KMT2A (0.32) RORCPKMMAPK1KMT2ASLC6A9
SCHEMBL16784631 0.87 DPP4 (0.36) DPP4DPP8DPP9DPP7MDM2
SCHEMBL16229805 0.86 SLC6A9 (0.38) DPP4DPP8DPP9DPP7SCN9A
SCHEMBL16229754 0.84 RORC (0.32) RORCGAA
SCHEMBL16229766 0.83 TP53 (0.35) TP53PKMMAPK1SLC6A9
SCHEMBL16229778 0.83 NR1D1 (0.33) PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9051280-B2 Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy AbbVie Deutschland GmbH & Co. KG (DE) 2015-06-09 US disclosed
US-8883839-B2 Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy ABBOTT LABORATORIES (US) 2014-11-11 US disclosed